Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZVRA | LYEL | ORGO | ||
| Company | Zevra Therapeutics Inc | Lyell Immunopharma Inc | Organogenesis Holdings Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.02 | 22.90 | 3.97 | ||
| High | 9.07 | 24.96 | 3.98 | ||
| Low | 8.69 | 22.86 | 3.78 | ||
| Latest | 8.93 | 23.76 | 3.79 | ||
| Change | -0.09 | +0.83 | -0.18 | ||
| % Change | -1.00% | +3.62% | -4.53% | ||
| Volume | 747,000 | 152,200 | 764,200 | ||
| 20-Day Average Volume | 1,008,410 | 138,915 | 1,140,545 | ||
| Previous Close | 9.02 | 22.93 | 3.97 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.63 | 29.34 | 4.78 | ||
| 20-Day Raw Stochastic | 74.80% | 6.10% | 0.70% | ||
| 20-Day Relative Strength | 52.23 | 43.99 | 33.83 | ||
| Weighted Alpha | -4.64 | +25.98 | -19.42 | ||
| Today's Opinion | 56% Sell | 56% Buy | 8% Sell | ||
| Previous Opinion | 56% Sell | 56% Buy | 8% Sell | ||
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.18% since 01/09/26 | -3.22% since 01/09/26 | -9.98% since 01/09/26 | ||
| Low | 8.08 on 01/12/26 | 22.38 on 01/15/26 | 3.78 on 01/16/26 | ||
| High | 9.24 on 01/14/26 | 25.12 on 01/13/26 | 4.28 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | +9.98% since 12/16/25 | -27.21% since 12/16/25 | -26.69% since 12/16/25 | ||
| Low | 8.01 on 12/19/25 | 22.38 on 01/15/26 | 3.78 on 01/16/26 | ||
| High | 9.24 on 01/14/26 | 45.00 on 12/22/25 | 5.91 on 12/24/25 | ||
| 3-Month | |||||
| %Chg | -21.53% since 10/16/25 | +39.76% since 10/16/25 | -6.65% since 10/16/25 | ||
| Low | 8.01 on 12/19/25 | 15.72 on 11/04/25 | 3.78 on 01/16/26 | ||
| High | 11.45 on 10/17/25 | 45.00 on 12/22/25 | 7.08 on 11/11/25 | ||
| 6-Month | |||||
| %Chg | -27.52% since 07/16/25 | +149.32% since 07/16/25 | -15.12% since 07/16/25 | ||
| Low | 7.16 on 09/17/25 | 9.11 on 07/17/25 | 3.58 on 08/08/25 | ||
| High | 12.80 on 07/18/25 | 45.00 on 12/22/25 | 7.08 on 11/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 502,741 | 504,757 | 480,997 | ||
| Shares Outstanding, K | 56,298 | 21,244 | 126,912 | ||
| Annual Sales | 23,610,000 | 60,000 | 482,040,000 | ||
| Annual Net Income | -105,510,000 | -342,990,000 | 860,000 | ||
| Last Quarter Sales | 26,060,000 | 20,000 | 150,860,000 | ||
| Last Quarter Net Income | -540,000 | -38,850,000 | 21,570,000 | ||
| 60-Month Beta | 1.08 | -0.13 | 1.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.01 on 11/05/25 | -2.13 on 11/12/25 | 0.18 on 11/06/25 | ||
| Latest Earnings Date | 03/10/26 | 03/10/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||